439 related articles for article (PubMed ID: 26688036)
21. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: hydration and dehydration of theophylline.
Amado AM; Nolasco MM; Ribeiro-Claro PJ
J Pharm Sci; 2007 May; 96(5):1366-79. PubMed ID: 17455358
[TBL] [Abstract][Full Text] [Related]
22. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
Emeje MO; Kunle OO; Ofoefule SI
Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism in anhydrous theophylline--implications on the dissolution rate of theophylline tablets.
Phadnis NV; Suryanarayanan R
J Pharm Sci; 1997 Nov; 86(11):1256-63. PubMed ID: 9383736
[TBL] [Abstract][Full Text] [Related]
24. Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters.
Vanhoorne V; Vanbillemont B; Vercruysse J; De Leersnyder F; Gomes P; Beer TD; Remon JP; Vervaet C
Int J Pharm; 2016 May; 505(1-2):61-8. PubMed ID: 27041123
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
[TBL] [Abstract][Full Text] [Related]
26. Surelease as granulating liquid in preparation of sustained release matrices of ethylcellulose and theophylline.
Afrasiabi Garekani H; Faghihnia Torshizi M; Sadeghi F
Drug Dev Ind Pharm; 2015; 41(10):1655-60. PubMed ID: 25402967
[TBL] [Abstract][Full Text] [Related]
27. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
28. Role of excipients in hydrate formation kinetics of theophylline in wet masses studied by near-infrared spectroscopy.
Jørgensen AC; Airaksinen S; Karjalainen M; Luukkonen P; Rantanen J; Yliruusi J
Eur J Pharm Sci; 2004 Sep; 23(1):99-104. PubMed ID: 15324927
[TBL] [Abstract][Full Text] [Related]
29. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
[TBL] [Abstract][Full Text] [Related]
30. A study on maize proteins as a potential new tablet excipient.
Georget DM; Barker SA; Belton PS
Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
[TBL] [Abstract][Full Text] [Related]
31. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
32. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
[TBL] [Abstract][Full Text] [Related]
33. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
34. The stability of theophylline tablets with a hydroxypropylcellulose matrix.
Alvarez-Lorenzo C; Gómez-Amoza JL; Martínez-Pacheco R; Souto C; Concheiro A
Drug Dev Ind Pharm; 2000 Jan; 26(1):13-20. PubMed ID: 10677805
[TBL] [Abstract][Full Text] [Related]
35. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate).
Zhang F; McGinity JW
Drug Dev Ind Pharm; 2000 Sep; 26(9):931-42. PubMed ID: 10914317
[TBL] [Abstract][Full Text] [Related]
36. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
37. Development and evaluation of pulsatile drug delivery system using novel polymer.
Tekade AR; Gattani SG
Pharm Dev Technol; 2009; 14(4):380-7. PubMed ID: 19235549
[TBL] [Abstract][Full Text] [Related]
38. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
39. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
Jannin V; Pochard E; Chambin O
Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
[TBL] [Abstract][Full Text] [Related]
40. Design and evaluation of a controlled-release theophylline tablet. Preliminary communication.
Gai MN; Pezoa R; Corbeaux J; Arancibia A
Farmaco; 1989 Nov; 44(11):1119-26. PubMed ID: 2701966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
